Releases

Releases 20/09/2026 - 09:42
Guia MICHELIN Divulga Nomes Selecionados para a Chave MICHELIN de 2026 do Oriente Médio, África e Índia
Releases 20/09/2026 - 06:42
LEPAS Sedia Primeira Edição da Global Elegant Lifestyle Week em Outubro
Releases 20/09/2026 - 06:27
CGTN Enquete da CGTN / Por Que a Solução da SCO para Governança Global Chama Tanta Atenção?
Releases 20/09/2026 - 01:27
LEPAS Expands Global Presence with Progress Across Multiple Markets
Releases 19/09/2026 - 08:27
Dando Seguimento ao Seu Progresso Global, a LEPAS Irá Realizar a Primeira Edição da Global Elegant Lifestyle Week
Releases 19/09/2026 - 03:42
CGTNCGTN Poll / Why is the SCO Solution for Global Governance Drawing Wide Attention?
Releases 18/09/2026 - 17:42
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
Releases 18/09/2026 - 17:42
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults
Releases 18/09/2026 - 17:42
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs